Access cutting-edge urinary tract infection treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access urinary tract infection specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related urinary tract infection treatment provided free
The purpose of this study is to assess safety, reactogenicity, and immune response of the candidate UTI vaccine compared to placebo in adults between and including 18-64 years of age (YOA), and to perform a preliminary evaluation of clinical efficacy in females between and including 18-64 YOA.
Sponsor: GlaxoSmithKline
Check if you qualify for this urinary tract infection clinical trial in Seattle, WA
If you're searching for urinary tract infection treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced urinary tract infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.